Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity

Clinical and Experimental Immunology

Volumn 177, Issue 2, 2014, Pages 478-482

  Brauner, H ^a   Luthje P ^a,b   Grunler J ^b   Ekberg, N R ^b   Dallner, G ^b   Brismar, K ^b   Brauner, A ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; Human; Natural killer cells; Reactive oxygen species

Indexed keywords

ADENYLATE KINASE; POLYPEPTIDE ANTIBIOTIC AGENT; UBIDECARENONE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

DIABETES; HUMAN; NATURAL KILLER CELLS; REACTIVE OXYGEN SPECIES;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIOXIDANTS; BETA-DEFENSINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; KILLER CELLS, NATURAL; MIDDLE AGED; OXIDATIVE STRESS; UBIQUINONE;

EID: 84904012037     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12316     Document Type: Article

References (32)

1. Garcia C, Feve B, Ferre P etal. Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab 2010; 36:327-338.
2. Kalupahana NS, Moustaid-Moussa N, Claycombe KJ. Immunity as a link between obesity and insulin resistance. Mol Aspects Med 2012; 33:26-34.
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54:1615-1625.
4. Ciornei CD, Tapper H, Bjartell A, Sternby NH, Bodelsson M. Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC Cardiovasc Disord 2006; 6:49.
5. Bobryshev YV, Lord RS. Identification of natural killer cells in human atherosclerotic plaque. Atherosclerosis 2005; 180:423-427.
6. Edfeldt K, Agerberth B, Rottenberg ME etal. Involvement of the antimicrobial peptide LL-37 in human atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26:1551-1557.
7. Barnathan ES, Raghunath PN, Tomaszewski JE, Ganz T, Cines DB, Higazi Aa-R. Immunohistochemical localization of defensin in human coronary vessels. Am J Pathol 1997; 150:1009-1020.
8. Higazi AA, Nassar T, Ganz T etal. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis. Blood 2000; 96:1393-1398.
9. Niyonsaba F, Nagaoka I, Ogawa H. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol 2006; 26:545-576.
10. Diana J, Simoni Y, Furio L etal. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013; 19:65-73.
11. Lan CC, Wu CS, Huang SM etal. High-glucose environment inhibits p38MAPK signaling and reduces human beta-defensin-3 expression in keratinocytes. Mol Med 2011; 17:771-779.
12. Froy O, Hananel A, Chapnik N, Madar Z. Differential effect of insulin treatment on decreased levels of beta-defensins and Toll-like receptors in diabetic rats. Mol Immunol 2007; 44:796-802.
13. Malik AN, Al-Kafaji G. Glucose regulation of beta-defensin-1 mRNA in human renal cells. Biochem Biophys Res Commun 2007; 353:318-323.
14. Rivas-Santiago B, Trujillo V, Montoya A etal. Expression of antimicrobial peptides in diabetic foot ulcer. J Dermatol Sci 2012; 65:19-26.
15. Lan CC, Wu CS, Huang SM etal. High-glucose environment reduces human beta-defensin-2 expression in human keratinocytes: implications for poor diabetic wound healing. Br J Dermatol 2012; 166:1221-1229.
16. Vidal SM, Khakoo SI, Biron CA. Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr Opin Virol 2011; 1:497-512.
17. Becknell B, Caligiuri MA. Natural killer cells in innate immunity and cancer. J Immunother 2008; 31:685-692.
18. Brauner H, Elemans M, Lemos S etal. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J Immunol 2010; 184:2272-2280.
19. Gur C, Porgador A, Elboim M etal. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 2010; 11:121-128.
20. Rodacki M, Svoren B, Butty V etal. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007; 56:177-185.
21. Thomas SR, Witting PK, Stocker R. A role for reduced coenzyme Q in atherosclerosis? Biofactors 1999; 9:207-224.
22. Turunen M, Wehlin L, Sjoberg M etal. Beta2-integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10. Biochem Biophys Res Commun 2002; 296:255-260.
23. Sohet FM, Neyrinck AM, Pachikian BD etal. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol 2009; 78:1391-1400.
24. Dallner G, Stocker R. Coenzyme Q10. In: Coates PM, Betz JM, Blackman MR etal., eds. Encyclopedia of dietary supplements. Boca Raton, FL: CRC Press, 2010:157-165.
25. Schmelzer C, Döring F. Identification of LPS-inducible genes downregulated by ubiquinone in human THP-1 monocytes. Biofactors 2010; 36:222-228.
26. Schmelzer C, Kubo H, Mori M etal. Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-alpha gene expression signature in SAMP1 mice. Mol Nutr Food Res 2010; 54:805-815.
27. Schmelzer C, Lorenz G, Rimbach G, Döring F. In vitro effects of the reduced form of coenzyme Q(10) on secretion levels of TNF-alpha and chemokines in response to LPS in the human monocytic cell line THP-1. J Clin Biochem Nutr 2009; 44:62-66.
28. 10 on release of pro-inflammatory chemokines in the human monocytic cell line THP-1. Biofactors 2007; 31:211-217.
29. Theuri G, Dallner G, Brismar K, Tekle M. Effects of lifestyle on plasma levels of the IGF system and the antioxidants coenzyme Q10 and vitamin E in Kenyan rural and urban populations. Growth Horm IGF Res 2013; 23:68-75.
30. Barnea M, Madar Z, Froy O. Glucose and insulin are needed for optimal defensin expression in human cell lines. Biochem Biophys Res Commun 2008; 367:452-456.
31. Peraldi MN, Berrou J, Dulphy N etal. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol 2009; 182:1696-1705.
32. Blasius AL, Barchet W, Cella M, Colonna M. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells. J Exp Med 2007; 204:2561-2568.